Literature DB >> 6472591

Somatosensory evoked potentials and cortical blood flow during craniotomy for vascular disease.

L P Carter, P A Raudzens, C Gaines, R M Crowell.   

Abstract

It has been demonstrated that central conduction time (CCT) is slowed and that attenuation of cortical potentials occurs with reduced cerebral perfusion. During 11 craniotomies for aneurysm, arteriovenous malformation (AVM), or extracranial-intracranial (EC-IC) bypass, we continuously monitored somatosensory evoked potentials (SSEPs) and regional cortical blood flow (rCBF) as determined by a thermal flow probe. The CCT was calculated and correlated with the rCBF. In 8 of the 11 cases, the rCBF values varied within 1 SD of normal values derived from 25 measurements of nonischemic cerebral cortex. All initial CCT values were within 1 SD of normal, but 4 of 11 patients had a prolonged CCT intraoperatively. Three of these were associated with a low rCBF (14 to 31 ml/100 g/minute). One patient had postoperative confusion at the time of discharge. One patient who underwent AVM embolization had a permanent loss of SSEPs postoperatively, and his preexisting hemiparesis was more profound after operation. Finally, 1 patient's CCT improved after EC-IC bypass. This is a preliminary study that demonstrates the feasibility of monitoring CCT and rCBF during craniotomy. When rCBF values fall and the CCT slows, neurological deficit will probably occur.

Entities:  

Mesh:

Year:  1984        PMID: 6472591     DOI: 10.1227/00006123-198407000-00006

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  2 in total

Review 1.  Do evoked potentials have any value in anaesthesia?

Authors:  A M Lam
Journal:  Can J Anaesth       Date:  1987-05       Impact factor: 5.063

2.  Intraoperative monitoring using somatosensory evoked potentials. A position statement by the American Society of Neurophysiological Monitoring.

Authors:  J Richard Toleikis
Journal:  J Clin Monit Comput       Date:  2005-06       Impact factor: 2.502

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.